The Extracellular Matrix and Cardiac Pressure Overload: Focus on Novel Treatment Targets

Matthijs Snelders1, Meltem Yildirim1, A H Jan Danser2

  • 1Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.

Cells
|October 25, 2024
PubMed

Insights

This review examines how extracellular matrix changes in pressure-overloaded hearts worsen heart failure. It highlights new treatment targets for maladaptive cardiac remodeling.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Heart failure is a major health concern, often caused by hypertension-induced pressure overload.
  • Cardiac remodeling, involving extracellular matrix changes, significantly worsens heart failure progression.
  • Current heart failure treatments have limited long-term efficacy.

Purpose of the Study:

  • To review extracellular matrix alterations in pressure-overloaded hearts.
  • To summarize existing heart failure treatments.
  • To identify novel therapeutic targets for maladaptive cardiac remodeling.

Main Methods:

  • Review of scientific literature on cardiac remodeling and extracellular matrix.
  • Analysis of animal models with transverse aortic constriction-induced pressure overload.

Main Results:

  • Extracellular matrix remodeling is a key driver of heart failure progression under pressure overload.
  • Transverse aortic constriction models provide insights into maladaptive remodeling processes.

Conclusions:

  • Understanding extracellular matrix dynamics is crucial for developing effective heart failure therapies.
  • Novel treatment strategies targeting maladaptive remodeling show promise for managing pressure-overloaded hearts.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
2.6K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
8.9K